Company intelligence / Profile preview

Sichuan Weikeqi Biotechnology

Chengdu, Sichuan, China

Ownership: Private
Development stage: Other

Overview

Not a therapeutic clinical-stage company; provides natural compound isolation/purification for academic, pharma, and nutraceutical R&D. Their compounds have supported research on neuroprotection, antioxidant effects, gut health, and drug discovery platforms but there are no internally developed drugs in clinical trials

Therapeutic areas: NeurologyGastroenterologyOther
Modalities: Small moleculeNatural product
Industry: Drug Discovery Services

Partnerships

Multiple leading Chinese academic institutions and research institutes, including Tsinghua University, China Pharmaceutical University, Guangzhou University of Traditional Chinese Medicine, Sichuan University, Hong Kong Baptist University, Wuhan Institute of Virology, Chinese Academy of Sciences, University of Macau, and more

Beyond the preview

Go deeper on Sichuan Weikeqi Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sichuan Weikeqi Biotechnology.

Explore the full profile